BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD. Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Equities
688621
CNE100005139
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.7 CNY | -1.29% |
|
-9.63% | -38.78% |
Beijing Sun-Novo Pharmaceutical Research Co Ltd is a China-based company principally engaged in the provision of preclinical and integrated clinical research and development services for pharmaceuticals. The Company's main businesses cover comprehensive research and development services in innovative drug development, generic drug development and consistency assessment. The Companyâs services mainly comprise drug discovery, pharmacology and pharmacodynamics, pharmacy research, clinical research and bioanalysis. The Company provides services in pharmacological research, including raw drugs preparation process and structure confirmation, dosage selection, medical services, operational services, data management and statistical analysis services, risk management services and quality management. The Company mainly conducts its businesses in the domestic market.
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
42.7
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.78% | 658M | |
| +19.41% | 45.51B | |
| +38.65% | 39.36B | |
| -8.62% | 38.52B | |
| +26.95% | 30.74B | |
| -13.50% | 26.03B | |
| +10.74% | 25.92B | |
| +44.87% | 14.13B | |
| +34.36% | 12.73B | |
| -7.14% | 11.29B |
- Stock Market
- Equities
- 688621 Stock
- News Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
- Sun-Novo Pharma Logs 49.8% Jump in 2022 Profit
